Human Milk-Based Fortification No Aid for Extremely Preterm Infants
WEDNESDAY, Jan. 10, 2024 (HealthDay News) — Human milk-based fortification does not aid...
Read MoreJan 11, 2024
WEDNESDAY, Jan. 10, 2024 (HealthDay News) — Human milk-based fortification does not aid...
Read MoreJan 10, 2024
TUESDAY, Jan. 9, 2024 (HealthDay News) — For heavily transfused patients with lower-risk...
Read MoreJan 10, 2024
TUESDAY, Jan. 9, 2024 (HealthDay News) — Bipolar disorder (BD) increases the odds of...
Read MoreJan 9, 2024
MONDAY, Jan. 8, 2024 (HealthDay News) — Higher device-measured moderate- to...
Read MoreJan 9, 2024
MONDAY, Jan. 8, 2024 (HealthDay News) — Sibling death in childhood and early adulthood is...
Read MoreJan 9, 2024
MONDAY, Jan. 8, 2024 (HealthDay News) — For hospitalized adults who die or are transferred...
Read MoreJan 9, 2024
MONDAY, Jan. 8, 2024 (HealthDay News) — The American Red Cross has declared a national blood...
Read MoreJan 9, 2024
MONDAY, Jan. 8, 2024 (HealthDay News) — In children and adolescents, BNT162b2 was effective...
Read MoreJan 8, 2024
FRIDAY, Jan. 5, 2024 (HealthDay News) — Treatment with nirmatrelvir during acute severe...
Read MoreJan 8, 2024
FRIDAY, Jan. 5, 2024 (HealthDay News) — Video recordings implicate convulsive events in...
Read MoreJan 8, 2024
FRIDAY, Jan. 5, 2024 (HealthDay News) — Twenty-four people have been sickened from a...
Read MoreJan 8, 2024
During the COVID-19 pandemic, expedient vaccine production has been slowed by the shortage of safe and effective raw materials, such as adjuvants, essential components to enhance the efficacy of vaccines. Monophosphoryl lipid A...
Read MoreJan 8, 2024
Remdesivir (RDV) is the mainstay antiviral therapy for moderate to severe COVID-19. Although remdesivir was the first drug approved for COVID-19, information about its efficacy and safety profile is limited in a significant...
Read MoreJan 8, 2024
Vaccinations, for example flu vaccine, may be a cause of cross-reactive immunostimulation that prevents a larger spectrum of infections. However, whether SARS-CoV-2 vaccinations may also determine this effect is unclear. This...
Read MoreJan 8, 2024
Microsatellite stable colorectal liver metastases (MSS CLM) maintain an immunosuppressive tumor microenvironment (TME). Historically, immune-based approaches have been ineffective. VB-111 (ofranergene obadenovec) is a...
Read MoreJan 8, 2024
Coronavirus disease (COVID-19) vaccine hesitancy is a global challenge. In low- and middle-income countries (LMICs), the problem has persisted despite vaccine availability and decreasing infections. In Uganda, there is still...
Read MoreJan 8, 2024
SARS-CoV-2 receptor binding domain (RBD) mediates viral entry into human cells through its interaction with angiotensin converting enzyme 2 (ACE2). Most neutralizing antibodies elicited by infection or vaccination target this...
Read MoreJan 8, 2024
With growing rates of unregulated drug toxicity death and concerns regarding COVID-19 transmission among people who use drugs, in March 2020, prescribed safer supply guidance was released in British Columbia. This study...
Read MoreJan 8, 2024
Renal cell carcinoma (RCC) is one of the most common malignant tumor worldwide. Metastasis is a leading case of cancer-related deaths of RCC. Circular RNAs (circRNAs), a class of noncoding RNAs, have emerged as important...
Read MoreJan 8, 2024
Inflammatory bowel disease (IBD) is a global disease. We aim to summarize the latest epidemiological patterns of IBD at the national, regional and global levels to give well-deserved attention and outline facilitating measures...
Read More